FDA Clears Medtronic Stealth Axis for Cranial, ENT Uses

Medtronic’s Stealth Axis FDA clearance marks an expansion of its surgical system into cranial and ear, nose, and throat (ENT) procedures, following regulatory approval from the US Food and Drug Administration. The clearance builds on the system’s earlier authorisation for spine procedures in February 2026, positioning Stealth Axis as a unified platform that combines surgical […]

The post FDA Clears Medtronic Stealth Axis for Cranial, ENT Uses first appeared on HHM Global | B2B Online Platform & Magazine.